AGI-14100
AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.
Product Specifications
CAS Number
1448346-43-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
599.96
Molecular Formula
C29H22ClF4N5O3
Notes
Research use only, not for human use.
Receptor
Dehydrogenase
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx413065 100 Tests
Killer Cell Lectin-Like Receptor Subfamily B Member 1 (KLRB1) Antibody (PE)
Ask
View Details 
MBS6202879-01 0.1 mL
RBAF600 (E3 Ubiquitin-protein Ligase UBR4, N-recognin-4, Zinc Finger UBR1-type Protein 1, Retinoblastoma-associated Factor of 600kD, p600, 600kD Retinoblastoma Protein-associated Factor, UBR4, KIAA0462, KIAA1307, ZUBR1) (MaxLight 490)
Ask
View Details MBS6202879-02 5x 0.1 mL
RBAF600 (E3 Ubiquitin-protein Ligase UBR4, N-recognin-4, Zinc Finger UBR1-type Protein 1, Retinoblastoma-associated Factor of 600kD, p600, 600kD Retinoblastoma Protein-associated Factor, UBR4, KIAA0462, KIAA1307, ZUBR1) (MaxLight 490)
Ask
View Details 
bsm-42319M-APC-Cy5.5 100 µL
Human Lambda Light Chain Monoclonal Antibody, APC-Cy5.5 Conjugated
Ask
View Details